SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility as investors react to a record-breaking earnings beat and surging AI-driven backlog, which are being overshadowed by a planned multibillion-dollar financing effort. While the community is debating whether this capital raise signals aggressive long-term growth or unsustainable dilution and debt, many are actively monitoring the stock's massive infrastructure buildout to gauge its future trajectory.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer Inc. is seeing intense volatility and heavy retail selling following a massive capital raise announcement, with the community sharply divided over whether the dilution is a strategic move to fund significant order backlogs or a sign of deeper fundamental distress. Traders are actively debating the company's long-term viability amid ongoing concerns about management, governance, and recent market pressure on the broader AI infrastructure sector.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is experiencing extreme selling pressure and volatility as investors weigh ongoing geopolitical tensions and the Pentagon's designation of the company as a Chinese military-linked firm. The community is sharply divided, with frustrated retail holders debating whether current valuation levels represent a long-term bottom or if the stock is a persistent 'value trap' being manipulated by institutional shorts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and community members react to reports of military escalation in Iran, with heated discussions centered on President Trump's controversial remarks about inflation and concerns over the company's financial stability. The stock is seeing extreme volatility as market participants debate the geopolitical impact of these military strikes alongside intense political criticism regarding the administration's economic policies.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently drawing significant attention as investors react to a rebound in monthly vehicle deliveries and renewed focus on its Physical AI strategy, including mass-produced robotaxis and humanoid robotics. The community remains deeply divided, with many debating the impact of ongoing geopolitical tensions on Chinese ADRs while others highlight the company's technical innovation and potential for long-term growth as a major catalyst.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Montreal, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU is experiencing significant volatility as investors debate whether the recent sharp pullback is a healthy consolidation within a long-term gold bull cycle or a deeper reversal triggered by macro headwinds. The community remains deeply divided, with many traders aggressively 'buying the dip' on a hunch that precious metals will resume their upward trajectory, while others warn of potential downside risks if inflation and interest rate narratives shift.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold is facing downward pressure as traders weigh persistent inflationary data and hawkish Fed rate expectations against ongoing geopolitical tensions. While some investors argue it should act as a safe haven, the community is actively debating whether it remains a reliable inflation hedge or is merely tracking broader market liquidations.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is trending as traders debate whether its recent price action signals a massive volatility spike or a trap built on structural decay. Community discussion is sharply divided between those betting on an imminent market-wide breakdown and those actively shorting the ETF to exploit its long-term negative roll yield.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

Geo Group is attracting significant investor attention as market participants focus on the company's critical role in federal detention operations following recent legislative efforts to fund immigration enforcement. Community discussions are heavily centered on the potential for massive contract wins and the stock's long-term technical setup, with many investors closely monitoring upcoming earnings and government spending decisions for a significant momentum shift.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is capturing attention as analysts highlight its strong expansion path and unit growth despite a challenging consumer environment. The community is actively debating the stock's premium valuation versus its growth potential, drawing frequent comparisons to the long-term success story of Chipotle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On

Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On...

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

Aclaris (ACRS) delivered earnings and revenue surprises of +7.24% and +46.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating Upgraded by Guggenheim

Guggenheim upgraded Aclaris Therapeutics to a "strong-buy" rating in a research report on Monday...

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates

Rigel (RIGL) delivered earnings and revenue surprises of -40.54% and -2.39%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Aclaris Therapeutics Updates ATI-052 Phase 1 Data, Picks ATI-2138 for Phase 2b in Lichen Planus

Aclaris Therapeutics (NASDAQ:ACRS) provided a clinical program update on Tuesday, highlighting full top-line results from its phase I-A single-ascending dose (SAD) and multiple-ascending dose (MAD...

Aclaris Therapeutics (NASDAQ:ACRS) Major Shareholder Sells $1,359,000.00 in Stock

Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) major shareholder Braden Michael Leonard sold 300,000 shares of Aclaris Therapeutics stock in a transaction on Thursday, April 23rd. The...

Aclaris Therapeutics (NASDAQ:ACRS) Major Shareholder Braden Michael Leonard Sells 300,000 Shares

Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) major shareholder Braden Michael Leonard sold 300,000 shares of the stock in a transaction on Thursday, April 23rd. The shares were sold at...

Aclaris Therapeutics (NASDAQ:ACRS) Shares Gap Down - Here's What Happened

Aclaris Therapeutics (NASDAQ:ACRS) Shares Gap Down - Time to Sell...

Aclaris Therapeutics Touts ATI-052 Potential for 3-Month Dosing, More Phase 1 Data Incoming

Aclaris Therapeutics (NASDAQ:ACRS) used an H.C. Wainwright inflammatory skin diseases conference fireside chat to outline development plans and differentiation points for its lead biologic candidate...

Short Interest in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Increases By 49.4%

Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totaling 7,017,767 shares, an increase of 49.4% from the March 15th total of 4,697,214 shares. Based on an average...

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

ACRSAclaris Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACRS News